Authors: Baptista, T Lacruz, A Angeles, F Silvera, R de Mendoza, S Mendoza, MT Hernandez, L

Citation: T. Baptista et al., Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration, PHARMACOPS, 34(6), 2001, pp. 223-231

Authors: Baptista, T Hernandez, L Prieto, LA Boyero, EC de Mendoza, S

Citation: T. Baptista et al., Metformin in obesity associated with antipsychotic drug administration: A pilot study, J CLIN PSY, 62(8), 2001, pp. 653-655

Authors: Lacruz, A Baptista, T de Mendoza, S Mendoza-Guillen, JM Hernandez, L

Citation: A. Lacruz et al., Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment, MOL PSYCHI, 5(1), 2000, pp. 70-76

Authors: Baptista, T Lacruz, A Acosta, A Colasante, C de Quijada, M de Mendoza, S Mendoza, JM Hernandez, L

Citation: T. Baptista et al., Naltrexone does not prevent the weight gain and hyperphagia induced by theantipsychotic drug sulpiride in rats, APPETITE, 34(1), 2000, pp. 77-86

Authors: Baptista, T Lacruz, A de Mendoza, S Guillen, JMM Silvera, R Angeles, F Mendoza, MT Hernandez, L

Citation: T. Baptista et al., Body weight gain after administration of antipsychotic drugs: Correlation with leptin, insulin and reproductive hormones, PHARMACOPS, 33(3), 2000, pp. 81-88